Clinical Trial Highlights

• Low Doses of n-3 Fatty Acids Do Not Reduce Major Cardiovascular Events
• Stem Cell Transplantation Improves Heart Function and Survival in Chronic Heart Failure
• Ivabradine Added to Standard Therapy Improves Outcomes in Patients with Systolic HF
• Bilateral versus Single Internal Mammary CABG: One-Year Results from the ART Trial
• The Impact of EES versus SES on Long-Term Clinical Outcome: Results from the LESSON-I Study
• ATOLL Study Shows Intravenous Enoxaparin is Associated with Better Ischemic Outcomes in Primary PCI for STEMI than UHF
• ISAR-REACT 3A: Low-Dose UFH Better for Elective PCI
• Apixaban Reduces Stroke Risk in Patients with AF: Results from the AVERROES Trial
• Preventing Postpericardiotomy Syndrome with Colchicine: Results from the COPPS Study
• DANPACE: Dual-Chamber Pacing Preferred in Sick Sinus Syndrome
• ARB Therapy in the Setting of Paroxysmal AF: Results from the ANTIPAF Trial
• EINSTEIN DVT: Rivaroxaban Noninferior to Enoxaparin and Warfarin in Patients with DVT
• UFH and Fondaparinux in ACS Patients Undergoing PCI: Results from the FUTURA/OASIS-8 Trial
• New Potassium Binder Prevents Hyperkalemia in Patients with HF
• Elinogrel, a Reversible Platelet Inhibitor, Shows Promising Antiplatelet Activity in Nonurgent PCI
• Management of ACS in Developing Countries: The ACCESS Registry